Trofel

Quick links to important sections

Trofel

Treatment option: Pain, Chronic Pain

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trofel

Understanding Trofel

Trofel is a medication primarily utilized in the management of specific gastrointestinal conditions. It belongs to a class of drugs designed to address symptoms associated with chronic bowel dysfunction, specifically focusing on the regulation of fluid secretion in the intestines.

Mechanism of Action

The active component in Trofel works by targeting specific chloride channels located in the epithelial lining of the gut. By modulating these channels, the medication helps to normalize the consistency and frequency of bowel movements. This action is localized within the digestive tract, meaning the medication functions directly where the symptoms originate rather than affecting the entire body systemically.

Clinical Applications

Trofel is typically indicated for individuals experiencing persistent diarrhea related to specific underlying health conditions. Its development was focused on providing a therapeutic option for patients whose symptoms significantly impact their daily quality of life and where dietary changes alone have proven insufficient.

Key characteristics of the medication include:

  • Targeted approach: It focuses on the physiological processes of the intestinal wall.
  • Symptom management: Its primary goal is the reduction of stool frequency and the improvement of stool consistency.
  • Non-antimicrobial: Unlike some other gastrointestinal treatments, it does not function as an antibiotic, meaning it does not target bacteria but rather the body's own secretory processes.

What side effects are possible with Trofel?

Possible Side Effects and Safety Information

The official safety profile for Trofel (Tramadol Hydrochloride), an opioid analgesic, is established based on classifications documented by government health authorities. Adverse reactions are grouped by frequency and the physiological system affected, ensuring a medically grounded understanding of the drug's safety characteristics.

Frequency-Classified Adverse Reactions

The most frequently reported effects fall into the Very Common or Common categories, primarily impacting the Nervous System and Gastrointestinal Tract:

  • Very Common (Affecting 1 in 10 or more): Nausea, Dizziness, and Somnolence (drowsiness).
  • Common (Affecting 1 in 100 to less than 1 in 10): Vomiting, Constipation, Dry mouth, Headache, and Sweating.
  • Uncommon/Rare: Less frequent effects include palpitations, orthostatic hypotension, gastrointestinal irritation, rash, and seizures. Serious allergic reactions (anaphylaxis) and motor weakness are classified as rare.
  • Not Known: The frequency of conditions like Serotonin Syndrome and Hyponatremia (low sodium levels) cannot be accurately estimated from available data, though they are listed as documented safety concerns.

Documented Serious Safety Risks

Official prescribing information highlights specific safety risks that are serious or clinically significant. These include Respiratory Depression (potentially life-threatening breathing difficulties), the risk of Serotonin Syndrome, and the possibility of Seizures, which may occur even at therapeutic doses. As an opioid, the potential for developing Drug Dependence and experiencing withdrawal symptoms upon abrupt cessation is a core safety characteristic.

Population and Contextual Safety Notes

Regulatory documents include safety notes for specific populations and circumstances. Clearance of the drug is noted to be reduced in individuals with Hepatic or Renal Impairment, requiring specific oversight. Side effects such as nausea and dizziness are officially documented as more frequently observed at the start of treatment. The medication is also officially contraindicated in cases of acute intoxication with other CNS depressants (e.g., alcohol) and in individuals with uncontrolled epilepsy.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Trofel (Tramadol Hydrochloride) emphasizes that overdose is a potentially life-threatening emergency requiring immediate medical attention. The manifestations primarily involve the central nervous system (CNS) and respiratory system.

Documented Overdose Manifestations

  • CNS Depression: Profound sedation, stupor, and progression to coma.
  • Respiratory Failure: Severe, potentially fatal respiratory depression (slowed or shallow breathing).
  • Neurological Signs: Dose-dependent seizures (convulsions), which may occur due to the non-opioid actions of the drug.
  • Cardiovascular: Severe hypotension and bradycardia.
  • Syndromic Risk: The regulatory profile includes the risk of Serotonin Syndrome.

Emergency Actions and High-Risk Considerations

Immediate medical help must be sought for any suspected overdose. Emergency management, as described in official labeling, is primarily symptomatic and supportive. The administration of the opioid antagonist naloxone is required for respiratory depression, though regulators note it may only partially reverse Tramadol's effects.

Official documents warn that accidental ingestion of even one dose by a child can result in a fatal overdose. Furthermore, elderly or debilitated patients are cited as being at an increased risk for life-threatening respiratory depression following overdose. Patients must never crush, chew, or dissolve extended-release formulations, as this can lead to a rapid release of a potentially fatal dose.

Therapeutic Uses of Trofel

What Trofel Treats: Main Uses and Benefits

Trofel (Tramadol Hydrochloride), an opioid analgesic, is commonly used to help with symptoms related to physical discomfort that are moderate to moderately severe. This class of medication is generally considered relevant when supportive symptom management is appropriate, such as when symptoms are not adequately addressed by conventional agents.

The medication is commonly used across conditions presenting with systemic or localized discomfort, including postoperative pain, long-term osteoarthritis pain, and symptomatic support in oncology care. It helps address symptom clusters that may become intense or disruptive.

“Applied in clinical settings that involve acute or unstable symptom patterns, its use contributes to improved comfort during phases of increased distress.”

Management of Pain Intensity

Trofel is applied to address heightened symptom intensity, offering symptomatic relief that helps patients cope more steadily with difficult episodes and assists with maintaining functional stability. The medication contributes to easing the overall symptom load, providing supportive relief.


Quick Fact: Therapeutic domain: Symptoms related to physical discomfort

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Trofel?

Trofel (Tramadol Hydrochloride) eligibility is strictly defined by regulatory bodies based on patient characteristics and pre-existing conditions. Only adults and certain adolescents over 12 are eligible for standard use.


Absolute Contraindications (Must Not Use)

Use is strictly prohibited for children under 12 years of age in all circumstances. It is also contraindicated for adolescents under 18 recovering from tonsillectomy or adenoidectomy due to heightened respiratory risk. Patients are ineligible if they have significant respiratory depression, severe bronchial asthma, gastrointestinal obstruction (e.g., paralytic ileus), or if they have recently taken MAOIs (Monoamine Oxidase Inhibitors). Use is also forbidden for those with uncontrolled epilepsy.

Populations with Restricted or Limited Use

The medicine is not recommended for patients with severe hepatic or renal impairment or for individuals known to be CYP2D6 ultra-rapid metabolizers. Use is generally restricted during pregnancy and lactation due to the documented risk of Neonatal Opioid Withdrawal Syndrome and potential infant harm, respectively. Older adults (over 75) are eligible but require special consideration and close monitoring due to altered drug elimination. The extended-release formulation is not established for use in children under 18.

What should I know about interactions with other medicines?

Trofel has a documented interaction profile primarily structured around its relationship with key metabolic enzymes and drug transporters.

Pharmacokinetic Interactions

Official regulatory information states that Trofel is a substrate of the drug-metabolizing enzyme Cytochrome P450 3A4 (CYP3A4) and the efflux transporter P-glycoprotein (P-gp). Co-administration with other medicines that modulate these systems can significantly alter Trofel's systemic exposure.

Interacting Agent Category Mechanistic Basis Regulatory Constraint
Strong CYP3A4 Inhibitors Increase Trofel concentrations (AUC/ C max) Contraindicated or use requires specific maximum dose restriction.
Strong CYP3A4 Inducers Decrease Trofel concentrations (AUC/ C max) Contraindicated or avoided due to risk of reduced efficacy.
P-gp/Moderate CYP3A4 Inhibitors Increase Trofel concentrations to a lesser extent Use with caution; requires close monitoring or dose adjustment.

Specific interacting medicines explicitly listed in regulatory documents include strong CYP3A4 inhibitors such as ketoconazole and clarithromycin, and strong inducers such as rifampin and carbamazepine. The interaction profile also addresses potential additive pharmacodynamic effects when Trofel is used with other agents that act on shared physiological systems, necessitating careful use.

Mechanism of Action

Trofel operates through a multi-modal mechanism involving three distinct biological actions that converge to modify nociceptive signal processing within the central nervous system (CNS).

Central Receptor Activation and Signal Dampening

This mechanism involves the μ-opioid receptor, where the drug and its highly active metabolite act as agonists to initiate an inhibitory cascade. This action reduces the speed and intensity of signal transmission of neurons associated with nociception by limiting the release of key excitatory neurotransmitters (like Substance P and Glutamate).

Potentiation of Descending Inhibitory Pathways

A crucial second action is the weak inhibition of the reuptake of Norepinephrine and Serotonin by their respective transporters. This increases the concentration of these monoamines in the synapse, which enhances the action of descending inhibitory pathways, leading to suppression of ascending nociceptive input at the level of the spinal cord.

Multi-Modal Synergy and Central Enzyme Inhibition

The combination product integrates the central opioid and monoaminergic mechanisms with the non-opioid component's central inhibition of Cyclooxygenase (COX) enzyme activity. This provides a synergistic physiological effect that targets multiple points in the signaling cascade simultaneously, potentiating the central modification of nociceptive processing.

Dosage and Administration Information

Official Administration Guidelines

Trofel is a trade name for a medication whose core component is Tramadol Hydrochloride, a substance for which precise administration protocols have been defined. The medication is primarily available for Oral administration in both immediate-release (IR) and extended-release (ER) forms. The active substance is also authorized for Intravenous (IV), Intramuscular (IM), and Subcutaneous (SC) routes.


Dosage and Administration Schedules

Dosage Form Standard Starting Dose Maximum Daily Dose Frequency
Immediate-Release (IR) Typically 25 mg once daily, titrated gradually. 400 mg Every 4 to 6 hours as needed.
Extended-Release (ER) 100 mg once daily (for opioid-naïve patients). 300 mg Once daily (every 24 hours).

Standard IR dosing begins with a titration of 25 mg increments every 3 days to improve tolerability, eventually reaching maintenance doses of 50 mg to 100 mg.


Procedural Instructions and Adjustments

Route & Preparation: Oral tablets and capsules, particularly ER forms, must be swallowed whole with liquid and should not be crushed, split, or chewed. The medicine can generally be taken without regard to meals.

Population Adjustments: Official labeling outlines necessary dose modifications for certain groups:

  • Older Adults (>75 years): The IR maximum daily dose is generally restricted to 300 mg.
  • Severe Renal/Hepatic Impairment: Dosing intervals for the IR form are typically increased to 12 hours, with reduced maximum daily doses. Use of the ER form is generally not recommended in these populations.
  • Pediatric Use: Tramadol is generally not recommended for children under 12 years of age.

Duration of Use: The drug is intended to be used at the lowest effective dosage for the shortest necessary duration. Discontinuation of long-term use requires a gradual tapering process to prevent withdrawal symptoms.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Trofel


Evidence for Use in Chronic Pain

The evidence base for Trofel was studied for ongoing, chronic discomfort and primarily consists of Systematic Reviews and Meta-analyses that aggregate findings from numerous Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time in adults diagnosed with various conditions such as chronic low back pain. Researchers monitored patient-reported outcomes describing perceived discomfort and functional activity levels. Scientific literature reported that the average change in pain intensity measurements was often below the threshold considered minimally clinically important. The certainty of the evidence for these changes is frequently rated low in scientific literature reviews.


Evidence for Use in Osteoarthritis Pain

Trofel was studied for conditions such as osteoarthritis (OA) of the knee or hip using short-term RCTs. Studies explored outcomes related to physical discomfort and functional outcomes, such as joint mobility. Studies describe patterns related to pain intensity measurements and functional outcomes compared to a placebo. The typical observation period in these trials was 6 to 12 weeks, which is insufficient to determine the effects of sustained use over multiple years.


Evidence for Use in Acute Postoperative Pain

Research focusing on acute postoperative pain utilized very short-term, controlled RCTs in specific surgical populations. The findings describe patterns observed in these models where the compound was studied for changes in measured pain intensity compared to controls. The evidence focuses on the initial hours, providing limited information on the full post-recovery period.


Limitations and Areas of Ongoing Research

Authoritative scientific reviews highlight that follow-up durations were limited across the core efficacy trials, meaning long-term outcomes are not fully established. Research is ongoing to better understand the patterns observed over time and to clarify the certainty of evidence for specific chronic conditions.

Frequently Asked Questions (FAQ)

Common questions about Trofel (FAQ)


Q: Can Trofel cause long-term side effects?

Regulatory documents state that prolonged use of the active ingredient in Trofel carries risks, including the potential for developing tolerance, physical dependence, and addiction. Long-term use may also affect the body's endocrine system, potentially causing androgen deficiency (low hormone levels that can cause issues like low libido).


Q: Are there any foods or drinks I need to avoid while taking Trofel?

Official warnings indicate that combining the active ingredient with alcohol is strongly discouraged as this significantly increases the risk of serious side effects like profound sedation and serious breathing difficulties. The immediate-release formulation can generally be taken without regard to meals, meaning food does not significantly impact its use.


Q: Can Trofel make me dizzy or affect my ability to drive?

Official product information indicates that side effects like dizziness, somnolence (drowsiness), and blurred vision are commonly reported. Due to these effects, the medicine may impair mental and physical abilities required for hazardous tasks like driving or operating machinery. Caution is advised when engaging in activities that require full alertness.


Q: Why are there warnings about alcohol use with Trofel?

The official Boxed Warning highlights that combining the active ingredient with alcohol dramatically increases the risk of serious outcomes. The combination can lead to profound sedation, respiratory depression (life-threatening breathing difficulty), coma, and death. Alcohol is a central nervous system depressant, and combining it with this medication has dangerously additive effects.


Q: How quickly should I expect to feel the effects of Trofel?

According to the official pharmacokinetic studies, pain relief (analgesia) from the immediate-release tablet typically begins within approximately one hour after administration.


Q: How long does one dose of Trofel typically last in the body?

Official information regarding the drug's elimination from the body states that the mean terminal half-life of the active ingredient is approximately 6 to 7 hours. This value describes the time it takes for the concentration of the medicine to reduce by half.


Q: Does Trofel interact with common over-the-counter pain relievers?

The official interaction profile indicates that caution is necessary with non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin if a person is also taking blood thinners, as this may increase the risk of bleeding. Regulatory guidance emphasizes the importance of discussing all over-the-counter medicines with a healthcare provider to check for any potential interactions.


Q: What should I do if I miss a scheduled dose of Trofel?

The patient instructions provided in regulatory documents state that the official instruction for a missed dose is to avoid taking a double dose to make up for the missed one. Instead, the guidance is to proceed by taking the next scheduled dose at the regularly appointed time.


Q: Is it normal to feel a change in appetite when starting Trofel?

Yes, official safety information indicates that a change in appetite is a possible effect. Anorexia (loss of appetite) has been reported as an adverse reaction in clinical studies associated with the use of this medicine.


Q: Does Trofel have any official black box warnings?

Yes, the FDA label for the active ingredient includes a Boxed Warning. This regulatory warning addresses several serious risks, including the potential for addiction, abuse, and misuse, as well as the danger of life-threatening respiratory depression (severe breathing problems).


Q: Does Trofel affect liver function tests?

The active ingredient is extensively metabolized (processed) by the liver. Because of this, the medicine is generally not recommended for use in patients with severe hepatic (liver) impairment, and those with less severe impairment may require specific dosage adjustments.


Q: Does Trofel interact with herbal supplements like St. John's Wort?

Official warnings state that using the active ingredient with other serotonergic medicines or supplements (like St. John's Wort) must be closely monitored. This is because the combination can increase the risk of a serious condition called Serotonin Syndrome.


Q: Can Trofel cause mood changes or affect mental health?

Yes, official documentation lists effects such as drowsiness, anxiety, nervousness, confusion, and depression as possible side effects. The product information also carries warnings regarding suicide risk in certain groups of patients.


Q: Can I take Trofel if I have a heart condition?

The official warnings indicate that the medicine can cause severe low blood pressure (hypotension) and its use is discouraged in patients with circulatory shock. Regulatory guidance emphasizes the importance of discussing all pre-existing medical conditions, including heart conditions, with a healthcare provider.


Q: Why does the official leaflet mention a specific disease history?

The official documentation mentions specific disease histories, such as prior seizures or epilepsy, a history of head injury, or pre-existing lung problems, because these conditions can increase the patient's risk of experiencing serious, life-threatening side effects from the medication.


Q: How does Trofel affect other prescription medicines that cause drowsiness?

The official Boxed Warning advises that combining the active ingredient with other prescription medicines that cause drowsiness (known as CNS depressants) can result in profound sedation, respiratory depression, coma, and death. The regulatory standard states that concomitant use of these medicines must be closely monitored.


Q: Can I use Trofel if I have diabetes?

While not an absolute contraindication, diabetes is listed in official monographs as a medical problem that may affect how this medicine works. Official monographs note that patients should discuss this condition with a healthcare provider for appropriate monitoring.

How should Trofel be stored and disposed of?

The storage and disposal of Trofel (Tramadol Hydrochloride) must follow strict regulatory requirements for stability and controlled substances.

Official Storage Requirements

Detail Regulatory Requirement
Temperature Store at controlled room temperature (20 C to 25 C / 68 F to 77 F). Do not refrigerate.
Protection Keep in the tightly closed, light-resistant container. Protect from moisture.
Child Safety Keep out of the reach of children and store securely in a locked location (due to Schedule IV status).

Official Disposal Protocol

Regulatory guidance for disposal prioritizes drug take-back programs. If a program is unavailable, this product must be immediately flushed down the toilet. This specific instruction is given by the regulatory authority to reduce the risk of diversion or accidental exposure associated with this potent opioid analgesic.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trofel found in:

A-Z Index: